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Abstract Human epidermal stem cells express higher levels of
L1 integrins than their more differentiated daughters, transit
amplifying cells. In a search for additional stem and transit cell
markers we used proteomics and differential cDNA hybridisation
to compare keratinocytes fractionated on the basis of L1 integrin
expression. There were remarkably few differences between the
two populations and none of the RNAs differed in abundance by
more than 2-fold. Nevertheless, proteomics revealed upregulated
expression of epidermal fatty acid binding protein (PA-FABP,
also known as E-FABP), Annexin II and two keratin related
proteins in the transit population. An unknown high molecular
mass protein was upregulated in the stem cell population. The
upregulation of PA-FABP was confirmed by Northern blotting
and conventional and whole mount labelling of human epidermis.
We conclude that PA-FABP is a novel marker of epidermal
transit amplifying cells. ß 2000 Federation of European Bio-
chemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
Human epidermis is renewed throughout adult life by pro-
liferation of a subpopulation of cells in the basal layer, known
as stem cells [1,2]. Stem cells produce both stem and non-stem
daughter cells. The non-stem daughters, known as transit am-
plifying cells, proliferate a small number of times and then
undergo terminal di¡erentiation as they move through the
suprabasal epidermal layers to the tissue surface.
Although there are many markers that distinguish supra-
basal from basal keratinocytes there are very few that distin-
guish stem from transit amplifying cells [2]. One such marker
is expression of extracellular matrix receptors of the L1 integ-
rin family [3,4]. L1 integrins are expressed by all cells in the
basal layer of the epidermis, but keratinocytes with properties
of stem cells have 2^3-fold higher levels than transit amplify-
ing cells. L1 integrin expression can be used to enrich for stem
or transit amplifying cells, either from keratinocyte cultures or
direct from the epidermis, using FACS or di¡erential adhe-
siveness to extracellular matrix proteins. Using confocal mi-
croscopy it is also possible to visualise the relative location of
the di¡erent subpopulations [5]. The di¡erences in integrin
levels are functionally signi¢cant, because if a dominant neg-
ative integrin mutation is introduced into keratinocytes exit
from the stem cell compartment is stimulated [6].
Approximately 10% of cells in the epidermal basal layer are
thought to be stem cells, but the proportion of basal cells with
high L1 integrin expression varies between body sites and
ranges from 25% to over 40% [1,2,4]. There is therefore a
need for additional markers of stem and transit amplifying
cells. We have used two complementary approaches to search
for such markers. The ¢rst is to exploit the comprehensive
database of human keratinocyte proteins that has been estab-
lished using computer assisted two-dimensional (2D) gel elec-
trophoresis ([7] ; http://biobase.dk/cgi-bin/celis), as this allows
the analysis of thousands of keratinocyte proteins simultane-
ously. Such comparisons of keratinocytes grown under di¡er-
ent conditions have proven to be a powerful method for iden-
tifying disease and di¡erentiation associated proteins [8]. In
parallel, di¡erential hybridisations of arrayed cDNAs derived
from the UniGene human gene catalogue [9] allow for the
analysis of the expression of approximately 30 000 ESTs rep-
resenting di¡erent putative transcripts.
2. Materials and methods
2.1. Antibodies
For FACS and confocal microscopy, L1 integrins were detected
using mouse monoclonal antibody P5D2 [10]. PA-FABP was detected
in epidermal sheets using a rabbit antiserum raised against whole PA-
FABP referred to as anti-C-FABP (kindly provided by H. Fujii, De-
partment of Biochemistry, Niigata University School of Medicine,
Japan) [11,12]. Second layer antibodies used for immunostaining
were Alexa 594 or FITC conjugated goat anti-rabbit IgG and Alexa
488 or FITC conjugated goat anti-mouse IgG (Molecular probes,
Eugene, OR, USA).
2.2. Cell culture
Isolation of human keratinocytes from newborn foreskin and culti-
vation on a feeder layer of mitomycin C treated 3T3 cells have been
described previously [3,4,6]. Second or third passage precon£uent ker-
atinocytes (strains kp, kq) were used for protein and RNA analysis.
The culture medium consisted of one part Ham’s F12 medium and
three parts Dulbecco’s modi¢ed Eagle’s medium, supplemented with
1.8U1034 M adenine, 10% foetal calf serum, 0.5 Wg/ml hydrocorti-
sone, 5 Wg/ml insulin, 10310 M cholera toxin and 10 ng/ml epidermal
growth factor.
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2.3. FACS and adhesion selection of keratinocytes
For FACS, keratinocytes were harvested with trypsin/EDTA and
labelled with P5D2 and FITC conjugated secondary antibody, as
described previously [3,4,6]. Propidium iodide labelling was used to
gate out dead cells and suprabasal cells were gated out on the basis of
their high forward and side scatter [3,4]. Basal cells were sorted on the
basis of integrin expression on a Becton-Dickinson FACStar Plus.
The 20% of basal cells expressing the lowest and highest levels of
L1 integrins were collected as representatives of transit amplifying
and stem cell enriched populations, respectively [3,4]. The cells were
immediately lysed and extracted for isolation of protein or RNA.
Cells were also fractionated on the basis of adhesion to 100 Wg/ml
human type IV collagen, as described previously [3,4]. Cells that had
adhered after 20 min constituted the stem cell enriched fraction.
Cells that were to be subjected to 2D protein gel electrophoresis
were metabolically labelled prior to FACS or adhesion selection. Pre-
con£uent early passage primary human keratinocytes were incubated
at 37‡C for 18 h in methionine free Dulbecco’s modi¢ed Eagle’s
medium containing 10% FCS supplemented with 200 WCi/ml
[35S]methionine (Amersham) and 2.4 mg/ml unlabelled methionine.
2.4. 2D gel electrophoresis
Keratinocyte proteins labelled with [35S]methionine were extracted
and subjected to 2D gel electrophoresis (IEF, NEPHGE) using meth-
ods described previously [13,14]. The ¢rst dimension was performed
either as (i) IEF (18 h at 400 V) in 125U2 mm 4% polyacrylamide gels
containing 2% w/v carrier ampholytes (1.6%, pH 5^7, Serva; 0.4%,
pH 3.5^10, Pharmacia Biosystems AS) or (ii) NEPHGE (4.5 h at 400
V) in 125U2 mm 4% polyacrylamide gels containing 5% w/v carrier
ampholytes (3% w/v, pH 7^9, Pharmacia Biosystems AS; 2% w/v, pH
8^9.5, Pharmacia Biosystems AS). 1D gels were applied to the second
dimension and run at room temperature at 10 mAî for 4 h and at 3 mAî
overnight. Between one and two million trichloroacetic acid precipit-
able counts were applied per gel. Following £uorography, the dried
gels were exposed to X-ray ¢lm for 1^14 days.
2.5. Screening of cDNA arrays
Two sets of cDNA arrays were obtained from the Resource Centre
for the German Human Genome Project (RZPD; www.rzpd.de) in
Berlin [15]. 16 128 PCR products [9] from Image EST clones were
selected by S. Haas, S. Kirby, M. Peters, B. Toussiant, H. Lehrach,
A. Poustka, M. Vingron and B. Korn from the Unigene database and
spotted in duplicate on a 22U22 cm nylon ¢lter by the RZPD. The
membranes were hybridised with probes obtained from poly(A)+
RNA prepared from L1 integrin high and low expressing keratino-
cytes using the Dynabeads mRNA direct isolation kit (Dynal).
Poly(A)+ RNA from 1^3 million cells was reverse transcribed in the
presence of 100 WCi [33P]dCTP (NEN, speci¢c activity 3000 Ci/mmol)
in a 100-fold excess of cold dCTP. Following the hybridisation and
washing from 0.5USSC, 0.1% SDS to 0.1USSC, 0.1% SDS, the ¢lters
were exposed onto a phosphorimager screen (Molecular Dynamics)
and scanned after 4 days. The images were analysed using the pro-
grams Xdigitise V3 (developed by Huw Gri⁄ths; www.molgen.
mpg.de) and Cgen developed by W. Lehrach. Bacterial stabs for
Image clones of interest were obtained from the RZPD.
2.6. Northern blotting
Total keratinocyte RNA was extracted using Trizol (Gibco BRL).
Approximately 1 Wg total RNA was loaded on a 1% agarose gel
containing 0.0175 M MOPS salt, 80 mM sodium acetate, 0.25 mM
EDTA and 2 M formaldehyde and electrophoresed in the same con-
centration of MOPS. The RNA was blotted onto nylon membranes
(Hybond N+, Amersham). Membranes were prehybridised, hybridised
and washed using normal procedures. The bands were visualised
either by autoradiography or exposure to a phosphorimager plate
and subsequent scanning. A multiple tissue Northern blot was pur-
chased from Clontech and hybridised as described above. The PA-
FABP speci¢c probe was the full length cDNA obtained from the
RZPD (Image clone 772914).
2.7. Immuno£uorescence staining of epidermis
8 Wm frozen sections of neonatal human foreskin were brie£y ¢xed
in acetone, blocked for 30 min in PBS containing 0.2% v/v ¢sh skin
gelatin, then incubated with primary antibody followed by secondary
antibody. Antibodies were diluted in PBS containing 0.2% ¢sh skin
gelatin. Sections were washed extensively in PBS after each antibody
incubation.
Double labelling of whole mounts of epidermis from normal adult
cheek skin was performed as described previously [5]. Formalin ¢xed
epidermal sheets were simultaneously permeabilised and blocked by
incubation in 0.5% skim milk powder, 0.25% ¢sh skin gelatin (Sigma),
0.5% Triton X-100 in 0.9% NaCl, 20 mM HEPES, pH 7.2 (PB bu¡er)
for 30 min. The primary antibodies were diluted in PB bu¡er and
incubated at room temperature overnight with gentle agitation. The
epidermis was then washed in PBS containing 0.2% Tween 20 for 3^4
h with several changes of wash bu¡er. The incubation with secondary
antibodies was performed in the same way. A Zeiss 510 confocal
microscope was used to analyse the whole mounts: 50^100 optical
sections of each epidermal sheet were captured with an increment of
0.5^1.0 Wm.
Fig. 1. 2D protein gel electrophoresis of [35S]methionine labelled proteins extracted from basal keratinocytes expressing high (A) or low (B) lev-
els of L1 integrins. Positions of the following proteins are indicated by arrowheads: involucrin (Inv), unknown putative stem cell marker (SM),
Annexin II (Ann), actin, PA-FABP, S100A7, keratin related proteins (KV). Positions of molecular mass markers (kDa) are indicated.
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3. Results
3.1. Detection of di¡erentially expressed proteins by 2D gel
electrophoresis
Cultured human keratinocytes were incubated overnight in
[35S]methionine, then harvested, labelled with an antibody to
L1 integrins and subjected to FACS. After gating out dead
cells and suprabasal cells, basal cells were fractionated into
the 20% of cells with highest L1 integrin levels (stem cell
enriched) and the 20% of cells with lowest levels (transit am-
plifying cell enriched) [3,4]. The cells were extracted and sub-
jected to 2D protein gel electrophoresis. A total of 10 inde-
pendent pairs of cell lysates was analysed; a representative
pair of gels is shown in Fig. 1 and the results of all the experi-
ments are summarised in Table 1.
The overall pattern of expressed proteins was remarkably
similar in each cell population (Fig. 1). The degree of con-
tamination with suprabasal cells, evaluated by the level of
involucrin expression [14], was low and equal in each fraction
(Inv in Fig. 1). One unknown protein with a molecular mass
of over 90 kDa was upregulated in the integrin bright popu-
lation (SM in Fig. 1). Annexin II (Ann in Fig. 1) and psoriasis
associated fatty acid binding protein (PA-FABP [8]; also
known as epidermal FABP and FABP5 [16,17]) were upregu-
lated in integrin dull cells, as were keratin related proteins of
unknown origin (KV in Fig. 1). Although PA-FABP forms a
complex with S100 proteins [16,17], the S100 proteins were
not upregulated in the integrin dull fraction (see, for example,
S100A7, also known as psoriasin, in Fig. 1).
3.2. Detection of di¡erentially expressed genes by di¡erential
hybridisation of cDNA arrays
Filters arrayed with cDNAs of representative ESTs from
the Unigene human gene catalogue were hybridised with la-
belled cDNA from either the stem cell enriched or the transit
cell enriched population, sorted in exactly the same way as the
metabolically labelled cells in the 2D gel electrophoresis ex-
periments. The ¢lters comprised two sets of approximately
16 000 known cDNAs spotted in duplicate. On average 6000
spots and their duplicates showed a detectable signal. Each
pair of identical ¢lter sets was hybridised with three pairs of
independent probes from integrin bright and dull cells, so that
each probe was hybridised at least once to each ¢lter. Each
Fig. 2. Scatter pro¢les (from the Cgen program) of the average sig-
nals from hybridisation of cDNA extracted from keratinocytes ex-
pressing high (Stem) or low (Transit) levels of L1 integrins to ¢lters
containing two di¡erent cDNA arrays (A and B respectively). Du-
plicate signals for S100A2, keratin 14, PA-FABP and Annexin II
(Ann) are shown. The scales are the log of the normalised signal in-
tensities.
Fig. 3. Expression of PA-FABP in keratinocytes and other cell
types. A,B,D: Northern blots of keratinocytes (A,B) or multiple tis-
sues (D) were hybridised with a probe to PA-FABP and with L-ac-
tin (A,D) or 18S RNA (B) as a loading control. A: Keratinocytes
were fractionated by FACS on the basis of high (HI) or low (LO)
L1 integrin expression. B: Unfractionated keratinocytes (total popu-
lation; T) were compared with cells that adhered to type IV colla-
gen within 20 min (adherent, stem cell enriched; A) and cells that
did not adhere (enriched for transit amplifying and terminally di¡er-
entiating keratinocytes; NA). C: Immuno£uorescence staining of
human epidermis with antibody to PA-FABP. DP, dermal papilla;
RR, rete ridge. Scale bar: 50 Wm.
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¢lter was also hybridised with M13 reverse primer to deter-
mine the amount of DNA on each spot. We were therefore
able to exclude excessive variation in probe quality and to
normalise for the DNA content of each spot on the ¢lter
pairs. The three resultant data sets were then normalised on
the basis of total counts over all spots in the complex cDNA
hybridisations, and evaluated in pairs and also as the sum of
all equivalent experiments, to provide an average intensity at
each spot for both the transit cell enriched and stem cell
enriched populations.
The signal intensities of individual spots hybridised with
RNA from integrin bright and dull cells were plotted against
each other on a scatter plot, which automatically identi¢es
duplicates and allows annotation (Fig. 2). Only cDNAs for
which duplicate spots gave the same signal intensity were
evaluated (see, for example, keratin 14 and S100A2 in Fig.
2A). Clones that appeared to be di¡erentially expressed were
evaluated using the three normalised average signal intensities
in the sum of the three experiments. None showed a di¡erence
in expression above 2-fold, the minimum considered signi¢-
cant. The PA-FABP signal was 2-fold more abundant in in-
tegrin bright than integrin dull cells (Fig. 2B), but since the
absolute signal was relatively low, the result can only be taken
as an indication of potentially higher expression in the transit
amplifying population. No signal could be detected at the
Annexin II spot (Fig. 2B).
3.3. Veri¢cation of di¡erential expression of PA-FABP by
Northern blotting
The upregulation of PA-FABP mRNA in transit amplifying
cells was con¢rmed by Northern blotting of keratinocytes
fractionated on the basis of L1 integrin expression (Fig. 3A)
or adhesion to type IV collagen (Fig. 3B). The PA-FABP
signal was approximately 2-fold greater in integrin dull than
Fig. 4. Double immuno£uorescence labelling of epidermal whole mount with antibodies to L1 integrins (green) (B,C,E,F) and PA-FABP (red)
(A,C,D,F). Two 0.5 Wm optical sections (A^C and D^F) through the basal layer are shown. C and F are merged images of A and B and D
and E, respectively. The asterisks show regions where the basal layer overlies a dermal papilla. Scale bar: 100 Wm.
Table 1
Summary of the proteins that were di¡erentially expressed in keratinocytes enriched for stem cells or transit amplifying cells
Protein No. of gels in which
protein observed
Upregulated in stem
or transit?
No. of gels in which
protein upregulated
PA-FABP 10 transit 10
Annexin II 8 transit 7
Stem marker 8 stem 5
Keratin related 10 transit 7
A total of 10 gel pairs representing 10 independent samples of FACS sorted keratinocytes were analysed.
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integrin bright keratinocytes and showed a greater than 2-fold
reduction in rapidly adhering cells (stem cell enriched) com-
pared to cells that did not adhere to collagen within 20 min
(enriched for transit amplifying and terminally di¡erentiating
cells) (Fig. 3B). When a probe to PA-FABP was hybridised to
a Northern blot of a range of tissues, ubiquitous but variable
expression was observed, except in peripheral blood leuko-
cytes (PBL), in which no signal was detected (Fig. 3D).
3.4. Immuno£uorescence staining of PA-FABP in human
epidermis
In foreskin and breast skin, the L1 integrin bright cells,
which are stem cell enriched, overlie the tips of the dermal
papillae, where the basal layer comes closest to the skin sur-
face. The integrin dull cells occupy the rete ridges, where the
basal layer projects into the dermis [3^5]. Cross-sections of
neonatal foreskin stained with an antibody speci¢c to PA-
FABP showed staining in all the epidermal layers (Fig. 3C).
Staining in basal keratinocytes was predominantly nuclear,
whereas, as reported previously, in the upper layers cytoplas-
mic staining predominated [11,12,16]. Within the basal layer
small groups of cells overlying the dermal papillae (DP in Fig.
3C) showed a reduction in PA-FABP staining compared to
the cells of the rete ridges (RR in Fig. 3C).
The relative distribution of those basal cells expressing high
levels of L1 integrins or PA-FABP was examined by whole
mount labelling of the epidermis in combination with confocal
microscopy. A series of 0.5 Wm optical sections from a z-sec-
tion through the basal layer of the epidermis is shown in Fig.
4. The positions of the dermal papillae are shown with an
asterisk and correspond to clusters of cells with the highest
levels of L1 integrins (Fig. 4E,F). Nuclear staining of PA-
FABP was weak in those cells (Fig. 4D,F). In contrast, strong
nuclear staining of PA-FABP was observed in the integrin
dull basal cells, corresponding to the rete ridges (Fig. 4A^
C). The staining pattern with the antibodies to PA-FABP in
both conventional sections and whole mounts of epidermis
was thus consistent with PA-FABP being upregulated in
transit amplifying cells.
4. Discussion
We used 2D protein gel electrophoresis and di¡erential hy-
bridisation of arrayed cDNA libraries to look for new
markers of epidermal stem and transit amplifying cells. No
genes with expression levels di¡ering by more than a factor of
two were detected in the hybridisation of the cDNA arrays.
Several reported stem cell markers, such as L1 integrins and
Delta1, di¡er in expression relative to transit amplifying cells
by approximately 2-fold [18] and so would not have been
identi¢ed using the arrays, even if there was a corresponding
2-fold di¡erence in RNA levels. No di¡erential expression of
several other proposed markers, such as keratin 15, E-cadher-
in and the K6L4 integrin [18], was observed when analysed on
the ¢lters (data not shown).
Very few di¡erences between the two subpopulations of
keratinocytes were observed by 2D protein gel electrophoresis.
Although over 2500 keratinocyte proteins can be identi¢ed on
the gels [7], those that are optimally resolved are less than 90
kDa and can be labelled with methionine; thus many keratin-
ocyte proteins, including the integrins, are not detectable. One
potential stem cell marker was found, but it was not examined
further because it could not be identi¢ed from the existing
database of keratinocyte proteins [7,8]. Upregulation of An-
nexin II, two keratin related proteins and PA-FABP was ob-
served in the transit cell enriched fraction. The upregulation
of PA-FABP was con¢rmed on the cDNA arrays and veri¢ed
by Northern blotting of cultured keratinocytes and immuno-
localisation in human epidermis.
PA-FABP is a small (15 kDa), conserved protein that is
capable of binding long chain fatty acids, a characteristic of
all members of the FABP family [19]. It is expressed in a wide
range of cell types ([20,21]; Fig. 3D) and although usually
regarded as a cytoplasmic protein, it does, like other family
members, contain nuclear localisation sequences [22]. Expres-
sion of PA-FABP is upregulated in psoriatic epidermis, the
tissue from which it was originally cloned [6]. It is interesting
that PA-FABP was identi¢ed in our screen for transit ampli-
fying cell markers, because psoriasis is proposed to involve an
expansion of the transit amplifying compartment [23,24] and
PA-FABP is upregulated by c-Myc [25], which is known to
stimulate keratinocytes to become transit amplifying cells [26].
PA-FABP appears to be involved in the control of growth
and di¡erentiation in a number of cell types. The protein is
upregulated during neuronal migration and di¡erentiation
[22,27] and during nerve repair after crushing injury [21].
Heart FABP, which is identical to mammary derived growth
inhibitor, inhibits proliferation and stimulates di¡erentiation
of mammary epithelium [28]. Expression of intestinal FABP is
tightly associated with the inhibition of DNA synthesis in the
intestine [29]. It will be interesting to investigate whether PA-
FABP regulates proliferation or di¡erentiation of basal kera-
tinocytes, whether this is dependent on its nuclear localisation,
and how any e¡ect is linked to fatty acid transport and me-
tabolism [11,16].
Even allowing for the limitations of 2D protein gels and
cDNA arrays, we must conclude that very few genes show
signi¢cant di¡erences in expression between basal keratino-
cytes fractionated by FACS with antibodies to L1 integrins.
It is possible that the degree of enrichment for stem and
transit cells obtained on the basis of L1 integrin expression
[3,4] is too low to allow di¡erentially expressed genes to be
detected. It is also possible that di¡erences in gene expression
that are signi¢cant in intact epidermis are not maintained in
culture: for example, in vivo a higher proportion of integrin
dull than integrin bright cells are actively cycling [5], but this
is not the case in vitro [3,4,26]. Another possibility is that the
genes of interest are expressed at levels that are below the
limits of detection of the methods we used. Finally, it could
be that there really are very few intrinsic markers that distin-
guish stem from transit amplifying cells and that the most
signi¢cant changes in gene expression are transient, as in the
induction of c-Myc that can trigger exit from the stem cell
compartment [26]. As we continue to explore the properties of
epidermal stem cells we will need to design strategies to ac-
count for all these possibilities.
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